FDA warning letter
Closeout letter
Issue date
20 Jun 2019
Issuing office
Center for Drug Evaluation and Research
Posted date
2 Jul 2019
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Issue date
10 Feb 2023
FDA warning letter
Issue date
12 Jan 2022
Issuing office
Center for Drug Evaluation and Research | CDER
Posted date
25 Jan 2022
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs